Watching desmoid tumors to understand what changes over time
Part of Cancer clinical trials.
This study follows people with desmoid-type fibromatosis using scans and health information to see how the tumor behaves. It may help patients and doctors decide when “watch and wait” is the right approach and when treatment is needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older).
- A doctor has diagnosed you with desmoid-type fibromatosis (new or coming back).
- You can have scans with contrast dye using either MRI or CT.
- The tumor can be seen on a scan and is at least 1 cm.
- Your care team thinks it’s safe to manage your condition with active observation (watching) for now.
- You can sign informed consent and understand the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment called arterial embolization for desmoid tumors (non-cancerous growths) that are causing symptoms and growing. The goal is to see if blocking the blood supply to the tumor can shrink it or stop it from growing.
This study tests whether radiofrequency ablation (using heat to destroy the tumor) is safe and effective for treating desmoid tumors. If you have a growing or symptomatic desmoid, this treatment might help without major surgery.
This trial studies people with fibromuscular dysplasia (FMD) and related conditions to learn what causes them and how they behave over time. You may also be able to join if you are a healthy person matched by age and gender to help compare results.
This study looks at the immune system of people with desmoid fibromatosis. It aims to understand how the immune system behaves in patients who are either watching their tumor (active surveillance) or getting treatment.
This study tests a new medication for adults with desmoid tumors (rare, slow-growing tumors that form in connective tissue). You may qualify if your tumor has grown recently, causes pain, or has come back after previous treatment.
This trial tests a procedure called arterial chemoembolization (TACE) for people with symptomatic desmoid tumors that are growing and cannot be treated with surgery or cryoablation. The goal is to see if this targeted treatment can control the tumor and relieve symptoms.
Hear when a new Desmoid Fibromatosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.